(C3RY) Cherry - Ratings and Ratios
Keyboards, Mice, Switches, Headsets
Description: C3RY Cherry
Cherry SE is a German-based company that specializes in the manufacture and sale of computer input devices, catering to a diverse range of sectors including office, gaming, healthcare, security, and IoT. The companys product portfolio encompasses keyboards, mice, desktop sets, and other peripherals, as well as software solutions. With a distribution network that includes various channels such as distributors, resellers, and e-tailers, Cherry SE has established a significant presence in the technology hardware market.
From a technical analysis perspective, Cherry AGs stock (C3RY) has shown fluctuations in recent times. The current price of €1.02 is above its 20-day and 50-day Simple Moving Averages (SMA) of €0.89 and €0.83, respectively, indicating a potential uptrend. However, the stock is below its 200-day SMA of €1.05, suggesting that the long-term trend is still uncertain. The Average True Range (ATR) of 0.08 represents a 7.51% volatility, indicating moderate price swings.
Fundamentally, Cherry SE operates in the Technology Hardware, Storage & Peripherals sub-industry, with a market capitalization of €21.84M. The absence of a Price-to-Earnings (P/E) ratio and a negative Return on Equity (RoE) of -109.85% raises concerns about the companys profitability. However, its essential to consider that the company might be investing heavily in growth initiatives or restructuring, which could impact short-term profitability.
Based on the available technical and fundamental data, a forecast for Cherry AGs stock can be made. Considering the stocks current price is above its short-term SMAs and the ATR indicates moderate volatility, a potential price target could be around €1.20-€1.30 in the short term, representing a 15-20% increase from current levels. However, the absence of a P/E ratio and negative RoE suggest that the companys financial performance needs to improve to sustain long-term growth. If Cherry SE can address its profitability concerns, the stock might be poised for a more significant rebound, potentially targeting the 52-week high of €2.74. Conversely, if the company fails to improve its financials, the stock might revisit its 52-week low of €0.52.
C3RY Stock Overview
| Market Cap in USD | 21m |
| Sub-Industry | Technology Hardware, Storage & Peripherals |
| IPO / Inception |
C3RY Stock Ratings
| Growth Rating | -65.6% |
| Fundamental | 33.1% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -68.7% |
| Analyst Rating | - |
C3RY Dividends
Currently no dividends paidC3RY Growth Ratios
| Growth Correlation 3m | -89% |
| Growth Correlation 12m | 11% |
| Growth Correlation 5y | -96.8% |
| CAGR 5y | -58.00% |
| CAGR/Max DD 5y | -0.59 |
| Sharpe Ratio 12m | -0.04 |
| Alpha | -79.42 |
| Beta | 1.002 |
| Volatility | 70.79% |
| Current Volume | 12.3k |
| Average Volume 20d | 12.3k |
| Stop Loss | 0.7 (-13.6%) |
| Signal | 1.64 |
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (-47.9m TTM) > 0 and > 6% of Revenue (6% = 6.33m TTM) |
| FCFTA -0.04 (>2.0%) and ΔFCFTA 12.94pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 42.24% (prev 37.32%; Δ 4.92pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.02 (>3.0%) and CFO -2.61m > Net Income -47.9m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 2.38 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (23.1m) change vs 12m ago -1.54% (target <= -2.0% for YES) |
| Gross Margin 19.38% (prev 5.30%; Δ 14.08pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 58.38% (prev 60.54%; Δ -2.16pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -18.51 (EBITDA TTM -37.5m / Interest Expense TTM 2.51m) >= 6 (WARN >= 3) |
Altman Z'' -6.92
| (A) 0.30 = (Total Current Assets 77.0m - Total Current Liabilities 32.4m) / Total Assets 149.9m |
| (B) -1.42 = Retained Earnings (Balance) -212.1m / Total Assets 149.9m |
| warn (B) unusual magnitude: -1.42 — check mapping/units |
| (C) -0.26 = EBIT TTM -46.5m / Avg Total Assets 180.7m |
| (D) -2.41 = Book Value of Equity -188.9m / Total Liabilities 78.4m |
| Total Rating: -6.92 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 33.08
| 1. Piotroski 2.0pt = -3.0 |
| 2. FCF Yield -12.87% = -5.0 |
| 3. FCF Margin -5.23% = -1.96 |
| 4. Debt/Equity 0.45 = 2.40 |
| 5. Debt/Ebitda -0.85 = -2.50 |
| 6. ROIC - WACC data missing |
| 7. RoE -51.25% = -2.50 |
| 8. Rev. Trend -61.60% = -3.08 |
| 9. Rev. CAGR -9.07% = -1.51 |
| 10. EPS Trend 9.23% = 0.23 |
| 11. EPS CAGR 0.0% = 0.0 |
What is the price of C3RY shares?
Over the past week, the price has changed by +1.76%, over one month by -8.58%, over three months by -18.18% and over the past year by -63.35%.
Is Cherry a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of C3RY is around 0.44 EUR . This means that C3RY is currently overvalued and has a potential downside of -45.68%.
Is C3RY a buy, sell or hold?
What are the forecasts/targets for the C3RY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 1 | 23.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 0.5 | -39.5% |
C3RY Fundamental Data Overview
Market Cap EUR = 17.8m (17.8m EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 6.70m EUR (Cash And Short Term Investments, last quarter)
P/S = 0.1684
P/B = 0.2428
Beta = 1.115
Revenue TTM = 105.5m EUR
EBIT TTM = -46.5m EUR
EBITDA TTM = -37.5m EUR
Long Term Debt = 24.9m EUR (from longTermDebt, last quarter)
Short Term Debt = 6.88m EUR (from shortTermDebt, last quarter)
Debt = 31.8m EUR (Calculated: Short Term 6.88m + Long Term 24.9m)
Net Debt = 36.1m EUR (from netDebt column, last quarter)
Enterprise Value = 42.9m EUR (17.8m + Debt 31.8m - CCE 6.70m)
Interest Coverage Ratio = -18.51 (Ebit TTM -46.5m / Interest Expense TTM 2.51m)
FCF Yield = -12.87% (FCF TTM -5.52m / Enterprise Value 42.9m)
FCF Margin = -5.23% (FCF TTM -5.52m / Revenue TTM 105.5m)
Net Margin = -45.42% (Net Income TTM -47.9m / Revenue TTM 105.5m)
Gross Margin = 19.38% ((Revenue TTM 105.5m - Cost of Revenue TTM 85.0m) / Revenue TTM)
Tobins Q-Ratio = -0.23 (set to none) (Enterprise Value 42.9m / Book Value Of Equity -188.9m)
Interest Expense / Debt = 2.32% (Interest Expense 739.0k / Debt 31.8m)
Taxrate = unknown
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 2.38 (Total Current Assets 77.0m / Total Current Liabilities 32.4m)
Debt / Equity = 0.45 (Debt 31.8m / last Quarter total Stockholder Equity 71.4m)
Debt / EBITDA = -0.85 (Net Debt 36.1m / EBITDA -37.5m)
Debt / FCF = -5.77 (Debt 31.8m / FCF TTM -5.52m)
Total Stockholder Equity = 93.5m (last 4 quarters mean)
RoA = -31.97% (Net Income -47.9m, Total Assets 149.9m )
RoE = -51.25% (Net Income TTM -47.9m / Total Stockholder Equity 93.5m)
RoCE = -39.28% (Ebit -46.5m / (Equity 93.5m + L.T.Debt 24.9m))
RoIC = unknown (NOPAT none, Invested Capital 113.1m, Ebit -46.5m)
WACC = unknown (E(17.8m)/V(49.6m) * Re(9.71%)) + (D(31.8m)/V(49.6m) * Rd(2.32%) * (1-Tc(none)))
Shares Correlation 5-Years: -97.50 | Cagr: -3.08%
Discount Rate = 9.71% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow -5.52m)
Revenue Correlation: -61.60 | Revenue CAGR: -9.07%
Rev Growth-of-Growth: -14.83
EPS Correlation: 9.23 | EPS CAGR: 0.0%
EPS Growth-of-Growth: 139.7